Concepedia
Statistics
Publications
26
Citations
872
H-Index
17
Active since
2015
Affiliations
Janssen (United States)(Current)
Janssen Scientific Affairs (United States)
Wilmington University
AstraZeneca (United States)
AstraZeneca (United Kingdom)
Bingcao Wu is an author at Janssen (United States) specializing in pharmacotherapy, medicine, and pharmacy.
Publications per year
2015–2024
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012
Bingcao Wu, Kelly Bell, Amy H. Stanford et al. · BMJ Open Diabetes Research & Care · 2016 · 215 citations · Full text
Medicine, Internal Medicine, Nephrology +15
Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation
Eric D. Peterson, Veronica Ashton, Yen-Wen Chen et al. · American Heart Journal · 2019 · 94 citations · Full text
Medicine, Cardiology, Pharmacotherapy +12
Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs
Alex C. Spyropoulos, Veronica Ashton, Yen-Wen Chen et al. · Thrombosis Research · 2019 · 67 citations
Medicine, Pharmacology, Pharmacotherapy +17
Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full‐term infants
Asunción Mejías, Bingcao Wu, Neeta Tandon et al. · Pediatric Allergy and Immunology · 2019 · 49 citations
Public Health, Child Health, Pediatrics +16
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
David M. Kern, Jill Davis, Setareh A. Williams et al. · International Journal of COPD · 2015 · 44 citations · Full text
Medicine, Health Informatics, Health Insurance +15
1–5 of 26